Thursday, May 5, 2011

Dynavax Q1 loss doubles to $18.5 million

Berkeley drug business Dynavax Technologies Corp. lost $18.5 million in the first quarter, more than double its loss of $9.2 million a year earlier.
The company (NASDAQ: DVAX) got a $6 million milestone payment from GlaxoSmithKline PLC (NYSE: GSK) after the end of the March quarter.

No comments:

Post a Comment